Fundraising FoxEldec Pharmaceuticals
Chapel Hill, US · Delaware corporation · 1 known investors
Find your way into Eldec Pharmaceuticals
Sign up to see every warm intro you have to Eldec Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Eldec Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Eldec is a biotechnology company developing peptide-based therapeutics targeting SPLUNC1's modulation of Orai1 activity, with lead programs ELD615 and ELD607 for lung diseases such as cystic fibrosis and non-CF bronchiectasis. Its research programs are supported by NHLBI, NIAID, NIDDK, and the North Carolina Biotechnology Center.
Founders & leadership
RT
Robert TarranCo-founder · President and CSOHe leads the Division of Genetic, Environmental and Inhalational Disease in the Department of Internal Medicine at the University of Kansas Medical Center, a role he took up in 2023 after nearly two decades at the University of North Carolina at Chapel Hill, where he was a professor in the Department of Cell Biology & Physiology. He was also the scientific founder of Spyryx, a respiratory therapeutics company.
SA
Saira AhmadCo-founder; Director of ScienceShe joined Eldec Pharmaceuticals in 2018 as a scientist and advanced through senior scientist to her current research leadership role. Her earlier work includes a postdoctoral fellowship and research associate position at the University of North Carolina at Chapel Hill, and doctoral studies at George Mason University, where she also served as a laboratory teaching assistant.
FS
Flori SassanoCo-founder; Director, Research Operations
RJ
Robert J. SchotzingerChairman and Chief Executive Officer
RH
Robert HughesChief Financial Officer
DJ
Dale J. ChristensenChief Development Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements$200K disclosed across 1 round · 2026
▶$200KraisedFeb 2026 · 1 investors · PharmaceuticalsRule 506(b)
▶$200KraisedFeb 2026 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert TarranExecutive Officer, Director
- Robert SchotzingerExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $200K
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Eldec Pharmaceuticals.
In the news
Frequently asked questions
- What does Eldec Pharmaceuticals do?
- Eldec is a biotechnology company developing peptide-based therapeutics targeting SPLUNC1's modulation of Orai1 activity, with lead programs ELD615 and ELD607 for lung diseases such as cystic fibrosis and non-CF bronchiectasis. Its research programs are supported by NHLBI, NIAID, NIDDK, and the North Carolina Biotechnology Center.
- Who founded Eldec Pharmaceuticals?
- Eldec Pharmaceuticals was founded by Robert Tarran, Saira Ahmad, Flori Sassano.
- Who are Eldec Pharmaceuticals's investors?
- Eldec Pharmaceuticals's investors include Cape Fear BioCapital.
- How much funding has Eldec Pharmaceuticals raised?
- Eldec Pharmaceuticals has disclosed $200K raised across 1 round.
- Where is Eldec Pharmaceuticals headquartered?
- Eldec Pharmaceuticals is headquartered in Chapel Hill, US.